Drug designed to raise HDL levels falls down
Karen Honey
Karen Honey
Published February 1, 2007
Citation Information: J Clin Invest. 2007;117(2):282-282. https://doi.org/10.1172/JCI31253.
View: Text | PDF
News

Figure 1

Options: View larger image (or click on image) Download as PowerPoint
The structure of torcetrapib, the heart disease drug whose development b...
The structure of torcetrapib, the heart disease drug whose development by Pfizer was halted in early December 2006.